Related Experiment Videos
Sudden cardiac death in patients with hypertension. An association with diuretics and beta-blockers?
A W Hoes1, D E Grobbee, J Lubsen
1Julius Center for Patient-Oriented Research, Utrecht University/Academic Hospital Utrecht, The Netherlands. A.W.Hoes@med.ruu.nl
Insights
Thiazide diuretics may increase sudden death risk, potentially due to potassium depletion. Potassium-sparing diuretics might be better tolerated, while beta-blockers require further investigation regarding sudden death risk.
Area of Science:
- Cardiology
- Pharmacology
- Hypertension Management
Background:
- Diuretics and beta-blockers are primary antihypertensive treatments.
- Their efficacy in preventing cardiovascular disease is established.
- This review focuses on their impact on sudden death incidence.
Purpose of the Study:
- To evaluate the effect of diuretics and beta-blockers on sudden death risk.
- To explore the potential mechanisms linking thiazide diuretics to adverse cardiac events.
- To compare the safety profiles of different diuretic classes regarding sudden death.
Main Methods:
- Pooled analysis of 7 trials with sudden death as an endpoint.
- Review of recent case-control studies on thiazide and beta-blocker use.
- Examination of evidence on potassium-sparing diuretic combinations.
Main Results:
- Non-potassium-sparing diuretics showed a pooled risk ratio of 1.5 for sudden death versus placebo.
- Thiazide diuretics exhibit a dose-dependent potassium-depleting effect.
- Recent studies suggest an increased sudden death risk with thiazides and potentially beta-blockers.
Conclusions:
- Thiazide diuretics may increase sudden death risk, possibly due to hypokalemia.
- Potassium-sparing diuretic combinations may offer a safer alternative to thiazide monotherapy.
- Further research is needed to confirm the association between beta-blockers and sudden death.
Abstract:
The cornerstones of current antihypertensive treatment are diuretics and beta-blockers and the efficacy of these drugs in preventing cardiovascular disease is undisputed. This article focuses on the effect of these 2 drug classes on the incidence of sudden death. Numerous studies have shown that thiazide diuretics have a strong, dosage-dependent potassium-depleting effect, and it has been postulated that this may explain why the reduction in risk of coronary heart disease, observed in hypertension trials, was less pronounced than expected. In 7 trials that included sudden death as an end-point; a pooled risk-ratio of sudden death of 1.5 (95% confidence interval 1.1 to 2.0) was observed when non-potassium-sparing diuretics were compared with placebo. Two recent case-control studies have also strongly indicated that the use of thiazides increases the risk of sudden death. Evidence from trials using potassium-sparing diuretic combinations suggests that these may be better tolerated than thiazide monotherapy. Although it was suggested in the 2 recent case-control studies that recipients of beta-blockers are also at an increased risk of sudden death, further studies are required to confirm this finding, particularly since these drugs have several well-documented cardioprotective effects.